Humana (HUM)
220.41
-3.14 (-1.40%)
NYSE · Last Trade: Jul 18th, 7:19 PM EDT
Detailed Quote
Previous Close | 223.55 |
---|---|
Open | 222.95 |
Bid | 215.25 |
Ask | 222.00 |
Day's Range | 206.87 - 224.17 |
52 Week Range | 206.87 - 406.46 |
Volume | 4,320,060 |
Market Cap | 28.32B |
PE Ratio (TTM) | 15.57 |
EPS (TTM) | 14.2 |
Dividend & Yield | 3.540 (1.61%) |
1 Month Average Volume | 1,621,038 |
Chart
About Humana (HUM)
Humana is a leading health insurance company that provides a wide range of health and wellness solutions to individuals, families, and employers. The organization offers Medicare Advantage plans, Medicaid services, and individual health insurance policies, focusing on enhancing the health and well-being of its members. Additionally, Humana invests in technology and innovative care management services, aiming to improve healthcare delivery and patient outcomes. The company is dedicated to integrating medical and wellness services to create a comprehensive approach to health management for its customers. Read More
News & Press Releases
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.
Via StockStory · July 18, 2025
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.
Via StockStory · July 18, 2025
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.
Via StockStory · July 18, 2025
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.
Via StockStory · July 18, 2025
Shares of specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN)
fell 3.2% in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.
Via StockStory · July 18, 2025
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.
Via StockStory · July 18, 2025
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.
Via StockStory · July 18, 2025
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively.
Via StockStory · July 18, 2025
Shares of Humana Inc. (NYSE: HUM) are trading lower Friday after the company lost a legal battle over Medicare bonus payments.
Via Benzinga · July 18, 2025
Shares of health insurance company Humana (NYSE:HUM)
fell 3.2% in the morning session after the company lost a lawsuit seeking to reverse cuts to its Medicare bonus payments.
Via StockStory · July 18, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · July 18, 2025
According to a report by Bloomberg, the company has approached private credit firms and is exploring financing terms that would include a payment-in-kind (PIK) feature.
Via Stocktwits · July 18, 2025
Stay updated with the S&P500 gap up and gap down stocks on Friday. Get a glimpse of the market's movement during today's session.
Via Chartmill · July 18, 2025
A federal district court in Texas sided with the government in dismissing the lawsuit, upholding the Centers for Medicare and Medicaid Services’ downgrade of Humana’s quality ratings.
Via Stocktwits · July 18, 2025
The escalation of tariff policies has intensified market volatility, with President Trump announcing a new wave of levies, including 30% tariffs on the European Union and Mexico starting August 1, a 35% tariff on Canadian goods, and a 10-15% baseline tariff proposed for over 150 countries, with up to 145%
Via MarketMinute · July 17, 2025
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Via Chartmill · July 17, 2025
Shares of Humana (HUM) are oversold. They are also close to support. This means the shares may be about to rally.
Via Benzinga · July 16, 2025
Humana Inc. [NYSE: HUM] announced today its latest collaboration with healthcare software company Epic, becoming the first health insurer to integrate health plan information directly into the MyChart accounts patients may already use with their healthcare providers.
By Humana Inc. · Via Business Wire · July 15, 2025
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
Via StockStory · July 15, 2025
Longevity Health Holdings Inc. (NASDAQ: XAGE) stock surged by 59.92% in the after-hours trading session on Monday, reaching $4.23. The rise follows an announcement of merger with THPlasma.
Via Benzinga · July 15, 2025
Leading health services company Humana Inc. (NYSE: HUM) is launching the inaugural Humana Cognitive GamesTM today to encourage older adults to exercise their minds and play an active role in maintaining their brain health.
By Humana Inc. · Via Business Wire · July 14, 2025
Humana will release its 2Q25 financial results, as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 30, 2025. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2025.
By Humana Inc. · Via Business Wire · July 9, 2025
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Via StockStory · July 9, 2025
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM), announced today a $500,000 donation to aid recovery efforts in Central Texas following the tragic flooding that struck over the July 4 holiday weekend. The Humana Foundation is coordinating efforts with its partner in the region, Reach Resilience, and is matching their donation of $500,000.
By Humana Inc. · Via Business Wire · July 8, 2025